fig3

Figure 3. Meta-analysis of the half-year survival in 4 studies comparing transarterial chemoembolization (TACE) plus stereotactic body radiation therapy (SBRT) with TACE or SBRT monotherapy in intermediate-to advanced-stage hepatocellular carcinoma patients